|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,641.50 DKK | -6.65% |
|
-3.10% | -19.02% |
| 05-09 | Genmab: Market mispricing creates opportunity as good Q1 reinforces investment thesis |  |
| 05-08 | Genmab says Orbis Investment Management Limited holds 5.08% of Genmab A/S as of May 8, 2026 | RE |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GENMAB A/S | Bio Therapeutic Drugs | -6.65% | -3.10% | -19.02% | +24.45% | -28.47% | 15.88B |  | |  |
- Stock Market
- Equities
- GMAB Stock
- Charts Genmab A/S
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition